Although double-J stents (DJS) are used to reduce complications following extracorporeal shock wave lithotripsy (ESWL), there has recently been a tendency to limit their use because of complications. We retrospectively reviewed 351 patients with renal stones larger than 30 mm to determine the effectiveness and the complications of DJS. While DJS were inserted prior to ESWL in 85 patients, 266 patients were treated without. The stone-free rate in the stented group was not significantly different from the non-stented group (31 and 30%). While the auxiliary treatment rate for the steinstrasse was 15% in the stented group, it was 18% in the non-stented group. Additionally, 4 of the stented patients (5%) were treated endoscopically because of encrustation or migration of the stent. Half of the patients in the stented group complained of mild bladder discomfort and disturbances which were relieved after removal of the DJS. We believe that DJS neither enhance stone passage nor reduce complications following ESWL, and therefore suggest their use only under certain conditions such as patients with solitary kidneys.

Keywords:
Double-J stents, Extracorporeal lithotripsy, Renal calculi
This content is only available via PDF.
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.